Biomedical Research | sciencenewsnet.in

Soup to Nuts

April 27, 2020 sarah Jonas Biomedical Research, corona virus, corona virus testing, covid 19, Diagnostics, Drug Screening, Medical Research, PPE, SARS-CoV-2, Therapeutics, Vaccine Development

The COVID-19 pandemic demands action on many fronts, from prevention to testing to treatment. Not content to focus its research efforts on just one, the laboratory of George Church in the Blavatnik Institute at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University is tackling the problem from seven different angles.

Research Results

UTEP Researchers Develop Nanohybrid Vehicle to Optimally Deliver Drugs Into the Human Body

April 23, 2020 sarah Jonas BIOCHEMISTRY, Biomedical Research, drug delivery vehicle, Oxidative Stress

The researchers discovered that encapsulating ellagic acid in chitosan, a sugar, reduces its inherent cytotoxicity while enhancing its anti-oxidant properties. The chitosan shell, which makes up the hard outer skeleton of shellfish, also permits EA delivery via a rapid burst phase and a relatively slow phase.

Feature

The director of NIH visits UAB as COVID-19 appears

March 24, 2020 sarah Jonas Biomedical Research, Coronavirus, COVID-19, NIH, remdesivir

Francis Collins, M.D., Ph.D., director of the NIH, flew to Birmingham on Thursday, March 5, to start a long-anticipated visit to UAB. Collins soon learned he had a problem back home. Maryland public health officials were reporting the first two cases of COVID-19 in the county where the NIH sits.

Research Results

Mayo Clinic researchers clarify how cells defend themselves from viruses

March 3, 2020 sarah Jonas Biomedical Research, Infection, Mayo Clinic

A protein known to help cells defend against infection also regulates the form and function of mitochondria, according to a new paper in Nature Communications.

Announcement

International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands

November 15, 2019 sarah Jonas 0 Comments Biomedical Research

Wistar and Leiden University Medical Center (LUMC) formalized a memorandum of understanding between the two institutions to explore a postdoctoral training exchange program in immunology, cancer research and vaccine biology. The Wistar-Schoemaker International Postdoctoral Fellowship would bring recent Ph.D. graduates trained at LUMC to Wistar to advance their research education under the mentorship of cutting-edge biomedical research leaders.

Announcement

Southwest National Primate Research Center Welcomes New Veterinarian

October 9, 2019 sarah Jonas 0 Comments Animal Research, Biomedical Research

Anna Goodroe, D.V.M., DACLAM, is the newest veterinarian to join the staff at the Southwest National Primate Research Center on the Texas Biomedical Research Institute campus. As an Assistant Veterinarian, she is part of the Veterinary Resources and Research Support team.

Announcement

CNS Gift to the CNS Foundation Doubles Innovative Clinical Research Initiative, Creating Annual NINDS/CNSF K12 Scholar Awards

October 2, 2019 sarah Jonas 0 Comments Biomedical Research, Brain, brain surgeon, Brain Surgery, Brain Tumor, Clinical Science, Congress of Neurological Surgeons, Education, Epilepsy, Foundation, Healthcare, MEDICAL EDUCATION, Medical Education Leadership, Medical Science, National Institutes of Health, Neurological Surgery, Neurological Surgery, P.C., Neurosurgeon, Neurosurgeons, Neurosurgery, neurosurgery and technology, neurosurgery awareness, Neurosurgery education, Neurosurgery Leadership, Philanthrophy, Philanthropic gift, philanthropic gifts, Surgeon

The Congress of Neurological Surgeons Foundation (CNS Foundation) announced a second K12 award will be funded by a generous gift from the Congress of Neurological Surgeons (CNS). The award is made possible through a collaboration with the Foundation of the National Institutes of Health (FNIH) and the National Institutes of Health (NIH).

Feature

Texas Biomed continues testing Ebola therapies and vaccines showing promise in outbreak areas

September 26, 2019 sarah Jonas 0 Comments Biomedical Advanced Research and Development Authority, Biomedical Research, Ebola

In mid-August 2019, human clinical trials were halted in the current Ebola epidemic that has claimed more than 2,100 lives in Africa. The findings resulted in the discontinuation of two of the drugs in the trial. Future patients will be randomly assigned to receive either REGN-EB3 (Regeneron) or mAb114 (Ridgeback Biotherapeutics) in an extension phase of the study. Texas Biomedical Research Institute scientists in the Institute’s Biosafety Level 4 contract research program conducted preclinical testing of several of the compounds in the trial, working with Regeneron and the Biomedical Advanced Research and Development Authority (BARDA).